In addition, JAK2 exon 12 mutations are detected in 2–3% of PV [4] and mutations in MPL, the receptor for thrombopoietin, have been reported in 5–10% of ET and PMF patients [5]–[8]. The gene discussed is JAK2; the disease is acquired polycythemia vera.